(Q33175868)

23 July 2017

title

Usefulness of pindolol in neurocardiogenic syncope (English)

1 reference

23 July 2017

0 references

Iskos D

1

1 reference

23 July 2017

Dutton J

series ordinal

2

1 reference

23 July 2017

Scheinman MM

series ordinal

3

1 reference

23 July 2017

Lurie KG

series ordinal

4

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

American Journal of Cardiology

23 July 2017

published in

1 reference

23 July 2017

volume

82

1 reference

23 July 2017

issue

9

1 reference

23 July 2017

page(s)

1121-4, A9

1 reference

Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Efficacy of Different Treatment Strategies for Neurocardiogenic Syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900568-2

10.1016/S0002-9149(98)00568-2

7 January 2021

Identifiers

DOI

1 reference

23 July 2017

1 reference